Amyris

OverviewSuggest Edit

Amyris is an integrated renewable products company providing sustainable alternatives to petroleum-sourced products and rare materials. The Company uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules, flexible building blocks that can be used in a wide range of products. Amyris is commercializing these products both as renewable ingredients in cosmetics, flavors, fragrances, polymers, lubricants, and consumer products and also as renewable diesel and jet fuels.
TypePublic
Founded2003
HQEmeryville, USMap
Websiteamyris.com
Employee Ratings3.5More
View Jobs (32)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)561(+12%)
Job Openings32
Revenue (FY, 2019)$152.6 M(+140%)
Share Price (Oct 2020)$3 (+3%)
Cybersecurity ratingCMore

Key People/Management at Amyris

John Melo

John Melo

Director, President & Chief Executive Officer
Eduardo Alvarez

Eduardo Alvarez

Chief Operating Officer
Kathleen Valiasek

Kathleen Valiasek

Chief Business Officer
Charles Kraft

Charles Kraft

Senior Vice President, Global Manufacturing & Process Development
Beth Baker Bannerman

Beth Baker Bannerman

Senior Vice President, Corporate Communications & Engagement
Nicole Kelsey

Nicole Kelsey

General Counsel and Secretary
Show more

Amyris Office Locations

Amyris has an office in Emeryville
Emeryville, US (HQ)
5885 Hollis St #100
Show all (2)

Amyris Financials and Metrics

Amyris Revenue

Embed Graph
View revenue for all periods
Amyris's revenue was reported to be $152.56 m in FY, 2019
USD

Revenue (Q2, 2020)

25.2m

Market capitalization (15-Oct-2020)

620.3m

Closing stock price (15-Oct-2020)

3.0

Cash (30-Jun-2020)

100.0m

EV

607.0m
Amyris's current market capitalization is $620.3 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

147.0m73.7m41.1m43.3m34.2m67.2m143.4m63.6m152.6m

Revenue growth, %

5%(21%)97%

Cost of goods sold

155.6m77.3m38.3m33.2m37.4m56.7m62.7m36.7m76.2m

Gross profit

(8.6m)(3.6m)2.9m10.1m(3.2m)10.5m80.7m26.9m76.4m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

32.0m36.3m29.5m19.3m19.1m7.9m10.8m7.0m6.0m9.3m16.3m7.9m7.8m8.6m8.8m9.6m26.5m13.0m25.7m24.2m23.0m23.2m14.9m14.4m62.7m35.0m29.1m25.2m

Cost of goods sold

29.1m35.7m43.8m23.6m4.4m9.0m8.9m8.3m6.2m7.5m10.1m6.6m11.0m8.5m11.2m7.9m14.9m12.8m17.3m17.6m5.3m6.0m8.6m17.7m15.1m20.7m11.8m

Gross profit

2.9m547.0k(14.3m)(4.4m)14.7m(1.1m)2.0m(1.3m)(195.0k)1.8m6.2m1.2m(3.1m)136.0k(2.4m)1.7m11.7m212.0k8.4m6.6m17.7m17.2m6.3m(3.3m)47.6m14.3m17.3m

Gross profit Margin, %

9%2%(49%)(23%)77%(14%)18%(19%)(3%)19%38%16%(40%)2%(27%)18%44%2%33%27%77%74%42%(23%)76%41%60%
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

95.7m30.6m6.9m42.0m12.0m27.2m57.1m45.4m300.0k

Accounts Receivable

6.9m3.8m7.7m8.7m4.0m62.8k33.6m3.9m

Prepaid Expenses

19.9m8.9m9.5m6.5m5.9m5.5m10.6m12.8m

Inventories

9.1m6.0m10.9m14.5m10.9m6.2m5.4m9.7m27.8m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

152.2m106.1m103.4m67.1m44.4m23.3m11.5m5.8m47.8m88.8m67.2m43.8m10.9m10.9m7.8m822.0k582.0k1.3m5.1m15.9m24.1m14.1m19.0m5.2m940.0k1.6m2.6m100.0m

Accounts Receivable

6.0m5.0m4.7m3.5m3.8m7.5m7.3m2.8m3.4m4.7m10.7m4.7m3.1m3.8m5.7m4.1m5.7m8.1m16.0m24.9m25.7m35.6m6.8m94.0k

Prepaid Expenses

5.2m9.4m9.1m10.1m10.0m9.1m7.1m7.2m9.6m7.1m6.6m7.1m8.9m7.0m3.7m4.0m4.3m5.7m7.4m9.2m7.3m5.5m8.2m9.8m12.8m12.8m14.5m

Inventories

6.9m8.5m8.9m8.8m8.3m6.5m4.1m7.9m11.1m14.8m16.7m11.4m11.1m11.1m7.6m10.0m7.9m7.1m5.7m6.4m5.0m6.6m6.3m8.5m14.0m15.9m31.1m33.1m
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(178.9m)(205.1m)(234.9m)2.2m(218.1m)(97.3m)(72.3m)(230.2m)(242.8m)

Depreciation and Amortization

11.1m14.6m16.6m15.0m12.9m11.4m11.4m4.9m4.6m

Inventories

(20.7m)2.9m(5.6m)(4.5m)4.5m5.7m(3.1m)(4.4m)(18.0m)

Accounts Payable

15.6m(11.8m)(2.6m)(3.2m)4.4m6.4m5.9m11.6m23.7m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(75.8m)(119.4m)(94.5m)(141.4m)(161.6m)(32.3m)(71.2m)(95.5m)16.4m(19.2m)(55.8m)(52.3m)(99.4m)(176.1m)(15.3m)(28.9m)(48.6m)(37.4m)(36.8m)(70.6m)(91.5m)(90.0m)(158.3m)(66.2m)(104.3m)(163.9m)(87.8m)(196.2m)

Depreciation and Amortization

4.8m7.7m3.7m7.5m10.7m4.4m8.5m12.3m3.8m7.5m11.3m3.5m6.8m9.9m2.9m5.7m8.6m2.7m5.6m8.1m1.6m2.9m4.0m848.0k1.7m2.7m1.7m4.1m

Inventories

(3.9m)(7.1m)(8.2m)130.0k612.0k(426.0k)1.2m(2.6m)209.0k(3.6m)(6.1m)2.2m3.4m3.3m3.9m1.9m3.9m(867.0k)409.0k(126.0k)420.0k(1.3m)(890.0k)1.2m(4.3m)(6.6m)(4.4m)(6.2m)

Accounts Payable

6.1m11.0m(2.4m)(9.1m)(11.2m)(1.6m)(1.9m)2.8m(946.0k)1.9m(903.0k)382.0k3.0m7.3m(810.0k)1.2m4.3m450.0k(1.7m)3.1m(108.0k)2.7m(5.2m)1.8m4.5m(2.0m)318.0k(27.9m)
show all
USDQ2, 2011

Financial Leverage

1.3 x
Show all financial metrics

Amyris Cybersecurity Score

Cybersecurity ratingPremium dataset

C

76/100

Learn more about about our premium products
SecurityScorecard logo

Amyris Online and Social Media Presence

Amyris's Trends

Embed Graph

Amyris News and Updates

September 11, 2020

Amyris Responds To LAVVAN's Filing Of Lawsuit On September 10, 2020

EMERYVILLE, Calif., Sept. 11, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, responds to LAVVAN, Inc.'s (LAVVAN) press...
July 29, 2020

SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc.

NEW YORK, July 28, 2020 /PRNewswire/ -- URGENT: SHAREHOLDER VOTE AUGUST 14, 2020 WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Amyris, Inc. ("AMRS" or the "Company") (NASDAQ: AMRS) in connection with the...
July 15, 2020

Amyris Launches Plant-derived Sustainable Silica for Clean Beauty Applications

EMERYVILLE, Calif., July 15, 2020 /PRNewswire/ -- Aprinnova, Inc., an Amyris, Inc. (Nasdaq: AMRS) joint venture, the leading supplier of high performance, clean beauty ingredients is commercializing a plant-derived silica made from sugarcane ashes. Silica is used widely in personal care...
June 22, 2020

Amyris Partners With AB Mauri North America To Reduce Sugar In Baking Products Using PURECANE™ Sweetener

The exclusive multi-year agreement is expected to transform the industrial baking sector in the US, Mexico and Canada markets EMERYVILLE, Calif., June 22, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading biotechnology company in the Clean Health and Beauty markets and a top...
June 04, 2020

Thinking about buying stock in Dolphin Entertainment, Mereo BioPharma, Amyris Inc, JetBlue Airways, or FuelCell Energy?

NEW YORK, June 4, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DLPN, MREO, AMRS, JBLU, and FCEL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
April 13, 2020

Amyris Experiences Very Strong Sales Start with Pipette Hand Sanitizer for the Whole Family

EMERYVILLE, Calif., April 13, 2020 /PRNewswire/ -- Amyris Inc. (NASDAQ: AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the full market launch and sales of its Pipette...
Show more

Amyris Blogs

December 03, 2018

Amyris Partners with Camil Alimentos to Deliver Zero Calorie Sweetener Made from Sugarcane to Brazilian Consumers

Agreement between the Brazilian multinational and the American company provides exclusivity for Latin America and aims to meet the growing consumer demand for natural non-calorie sweetening options EMERYVILLE, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc.
November 30, 2018

Amyris Partners with Givaudan to Introduce a Tabletop Application for its Zero Calorie, Naturally Sourced Sweetener

EMERYVILLE, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the research, development and production of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, recently announced the launch of a new,
November 15, 2018

Is Yeast the Future of Manufacturing?

By Meredith Salisbury and David Kirkpatrick  |  November 8, 2018, 2:36 PM  |  Techonomy Exclusive John Melo believes that the path to making sustainable development mainstream is to create environmentally-friendly products so appealing that demand forces the replacement of traditional manufacturing …
November 08, 2018

Amyris Further Expands Relationship with Yifan Pharmaceutical Co., Ltd.

Amyris Further Expands Relationship with Yifan Pharmaceutical Co., Ltd. Content Import Thu, 11/08/2018 - 08:30 Amyris Further Expands Relationship with Yifan Pharmaceutical Co., Ltd. Nov 8, 2018 This release is a backfill from a News Wire …
October 30, 2018

Amyris to Announce Third Quarter 2018 Financial Results on Tuesday, November 13, 2018

Amyris to Announce Third Quarter 2018 Financial Results on Tuesday, November 13, 2018 Content Import Tue, 10/30/2018 - 08:30 Amyris to Announce Third Quarter 2018 Financial Results on Tuesday, November 13, 2018 Oct 30, 2018 This release is a backfill from a Ne…
October 23, 2018

Amyris Partners with IPCA Labs to Earn the 2018 CPhI Award for Excellence in Pharma: API Development

Amyris Partners with IPCA Labs to Earn the 2018 CPhI Award for Excellence in Pharma: API Development Content Import Tue, 10/23/2018 - 08:31 Amyris Partners with IPCA Labs to Earn the 2018 CPhI Award for Excellence in Pharma: API Development Oct 23, 2018 This r…
Show more

 Amyris Frequently Asked Questions

  • When was Amyris founded?

    Amyris was founded in 2003.

  • Who are Amyris key executives?

    Amyris's key executives are John Melo, Eduardo Alvarez and Kathleen Valiasek.

  • How many employees does Amyris have?

    Amyris has 561 employees.

  • What is Amyris revenue?

    Latest Amyris annual revenue is $152.6 m.

  • What is Amyris revenue per employee?

    Latest Amyris revenue per employee is $271.9 k.

  • Who are Amyris competitors?

    Competitors of Amyris include Mingyang Smart Energy, Peter Greven and Ecoinno.

  • Where is Amyris headquarters?

    Amyris headquarters is located at 5885 Hollis St #100, Emeryville.

  • Where are Amyris offices?

    Amyris has an office in Emeryville.

  • How many offices does Amyris have?

    Amyris has 2 offices.